Aceto Corporation  

(Public, NASDAQ:ACET)   Watch this stock  
Find more results for ACET
19.35
-0.52 (-2.62%)
Oct 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 19.30 - 19.94
52 week 15.62 - 25.25
Open 19.85
Vol / Avg. 115,621.00/198,830.00
Mkt cap 577.58M
P/E 19.02
Div/yield 0.06/1.24
EPS 1.02
Shares 29.07M
Beta 1.63
Inst. own 73%
Sep 5, 2014
Q4 2014 Aceto Corp Earnings Call - Webcast
Sep 4, 2014
Q4 2014 Aceto Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 3.98% 5.68%
Operating margin 6.47% 8.68%
EBITD margin - 10.26%
Return on average assets 5.45% 7.33%
Return on average equity 9.75% 13.54%
Employees 270 -
CDP Score - -

Address

4 Tri Harbor Ct
PORT WASHINGTON, NY 11050-4661
United States - Map
+1-516-6276000 (Phone)
+1-516-6276093 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aceto Corporation (Aceto) is primarily engaged in the sourcing, regulatory support, quality assurance, marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries. The Company operates in three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Company has presence in China, Germany, France, the Netherlands, Singapore, India, Hong Kong, the United Kingdom and the United States, along with warehouses worldwide. In May 2014, the Company completed the acquisition of PACK Pharmaceuticals, LLC.

Officers and directors

Albert L. Eilender Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Salvatore J. Guccione President, Chief Executive Officer, Chief Operating Officer, Director
Age: 51
Bio & Compensation  - Reuters
Douglas A. Roth Chief Financial Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Satish Srinivasan President and Chief Operating Officer of Rising Pharmaceuticals
Age: 45
Bio & Compensation  - Reuters
Steven Rogers Senior Vice President, General Counsel, Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Charles J. Alaimo Senior Vice President - Human Resources
Age: 48
Bio & Compensation  - Reuters
Raymond Bartone Senior Vice President - Nutritionals
Age: 52
Bio & Compensation  - Reuters
Frank V. DeBenedittis Senior Vice President - Corporate Business Development
Age: 60
Bio & Compensation  - Reuters
Terry Kippley Senior Vice President - Agricultural Protection Products
Age: 50
Bio & Compensation  - Reuters
Carlos Restrepo Senior Vice President - Performance Chemicals
Age: 52
Bio & Compensation  - Reuters